Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q4682904> ?p ?o }
Showing triples 1 to 55 of
55
with 100 triples per page.
- Q4682904 subject Q10104935.
- Q4682904 subject Q18924462.
- Q4682904 subject Q6946436.
- Q4682904 subject Q8375173.
- Q4682904 subject Q8529670.
- Q4682904 subject Q8919936.
- Q4682904 abstract "Adinazolam (marketed under the brand name Deracyn) is a benzodiazepine derivative, and more specifically, a triazolobenzodiazepine (TBZD). It possesses anxiolytic, anticonvulsant, sedative, and antidepressant properties. Adinazolam was developed by Dr. Jackson B. Hester, who was seeking to enhance the antidepressant properties of alprazolam, which he also developed. Adinazolam was never FDA approved and never made available to the public market.".
- Q4682904 atcPrefix "N05".
- Q4682904 atcSuffix "BA07".
- Q4682904 casNumber "37115-32-5".
- Q4682904 chEBI "251412".
- Q4682904 drugbank "DB00546".
- Q4682904 fdaUniiCode "KN08449444".
- Q4682904 iupacName "1-(8-chloro-6-phenyl-4H-[1,2,4]triazolo[4,5-a][1,4]benzodiazepin-1-yl)-N,N-dimethylmethanamine".
- Q4682904 pubchem "37632".
- Q4682904 thumbnail Adinazolam.svg?width=300.
- Q4682904 wikiPageWikiLink Q10104935.
- Q4682904 wikiPageWikiLink Q18924462.
- Q4682904 wikiPageWikiLink Q210402.
- Q4682904 wikiPageWikiLink Q213373.
- Q4682904 wikiPageWikiLink Q225957.
- Q4682904 wikiPageWikiLink Q270421.
- Q4682904 wikiPageWikiLink Q3045264.
- Q4682904 wikiPageWikiLink Q319877.
- Q4682904 wikiPageWikiLink Q389934.
- Q4682904 wikiPageWikiLink Q408265.
- Q4682904 wikiPageWikiLink Q557945.
- Q4682904 wikiPageWikiLink Q576618.
- Q4682904 wikiPageWikiLink Q62903.
- Q4682904 wikiPageWikiLink Q6946436.
- Q4682904 wikiPageWikiLink Q7246819.
- Q4682904 wikiPageWikiLink Q76560.
- Q4682904 wikiPageWikiLink Q8375173.
- Q4682904 wikiPageWikiLink Q83871.
- Q4682904 wikiPageWikiLink Q847705.
- Q4682904 wikiPageWikiLink Q8529670.
- Q4682904 wikiPageWikiLink Q8919936.
- Q4682904 wikiPageWikiLink Q9368.
- Q4682904 wikiPageWikiLink Q9377.
- Q4682904 atcPrefix "N05".
- Q4682904 atcSuffix "BA07".
- Q4682904 casNumber "37115".
- Q4682904 chebi "251412".
- Q4682904 drugbank "DB00546".
- Q4682904 iupacName "1".
- Q4682904 pubchem "37632".
- Q4682904 unii "KN08449444".
- Q4682904 type ChemicalSubstance.
- Q4682904 type Drug.
- Q4682904 type ChemicalObject.
- Q4682904 type Thing.
- Q4682904 type Q8386.
- Q4682904 comment "Adinazolam (marketed under the brand name Deracyn) is a benzodiazepine derivative, and more specifically, a triazolobenzodiazepine (TBZD). It possesses anxiolytic, anticonvulsant, sedative, and antidepressant properties. Adinazolam was developed by Dr. Jackson B. Hester, who was seeking to enhance the antidepressant properties of alprazolam, which he also developed. Adinazolam was never FDA approved and never made available to the public market.".
- Q4682904 label "Adinazolam".
- Q4682904 depiction Adinazolam.svg.